JP2010526106A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526106A5
JP2010526106A5 JP2010506709A JP2010506709A JP2010526106A5 JP 2010526106 A5 JP2010526106 A5 JP 2010526106A5 JP 2010506709 A JP2010506709 A JP 2010506709A JP 2010506709 A JP2010506709 A JP 2010506709A JP 2010526106 A5 JP2010526106 A5 JP 2010526106A5
Authority
JP
Japan
Prior art keywords
sulfonamido
dibenzo
furan
acid
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/062593 external-priority patent/WO2008137816A2/en
Publication of JP2010526106A publication Critical patent/JP2010526106A/ja
Publication of JP2010526106A5 publication Critical patent/JP2010526106A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506709A 2007-05-04 2008-05-05 マトリックスメタロプロテアーゼインヒビターとしての三環式化合物 Withdrawn JP2010526106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92756307P 2007-05-04 2007-05-04
PCT/US2008/062593 WO2008137816A2 (en) 2007-05-04 2008-05-05 Tricyclic compounds as matrix metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
JP2010526106A JP2010526106A (ja) 2010-07-29
JP2010526106A5 true JP2010526106A5 (cg-RX-API-DMAC7.html) 2012-05-17

Family

ID=39944224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506709A Withdrawn JP2010526106A (ja) 2007-05-04 2008-05-05 マトリックスメタロプロテアーゼインヒビターとしての三環式化合物

Country Status (11)

Country Link
US (1) US20100227859A1 (cg-RX-API-DMAC7.html)
EP (1) EP2144893A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010526106A (cg-RX-API-DMAC7.html)
AR (1) AR066412A1 (cg-RX-API-DMAC7.html)
CA (1) CA2685389A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008001257A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009011749A (cg-RX-API-DMAC7.html)
PA (1) PA8779101A1 (cg-RX-API-DMAC7.html)
PE (1) PE20090223A1 (cg-RX-API-DMAC7.html)
TW (1) TW200900397A (cg-RX-API-DMAC7.html)
WO (1) WO2008137816A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008137583A (ru) * 2006-02-22 2010-03-27 Вертекс Фармасьютикалз Инкорпорейшн (Us) Спиропиперидины в качестве модуляторов мускариновых рецепторов
US9273021B2 (en) 2009-02-05 2016-03-01 Trustees Of Boston College Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof
RU2011144819A (ru) * 2009-04-06 2013-05-20 ПиТиСи ТЕРАПЬЮТИКС, ИНК Соединения и способы противовирусного лечения
WO2014123032A1 (ja) 2013-02-08 2014-08-14 三菱瓦斯化学株式会社 レジスト組成物、レジストパターン形成方法及びそれに用いるポリフェノール誘導体
JP6401773B2 (ja) * 2013-03-11 2018-10-10 ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン Betブロモドメイン阻害剤およびこれを用いる治療方法
EP2907512A1 (en) 2014-02-14 2015-08-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Inhibitors of MMP-12 as antiviral Agents
CN107108549A (zh) 2014-12-25 2017-08-29 三菱瓦斯化学株式会社 化合物、树脂、光刻用基底膜形成材料、光刻用基底膜、图案形成方法和纯化方法
CN107428717B (zh) 2015-03-31 2021-04-23 三菱瓦斯化学株式会社 抗蚀剂组合物、抗蚀图案形成方法、及用于其的多酚化合物
WO2016158168A1 (ja) * 2015-03-31 2016-10-06 三菱瓦斯化学株式会社 化合物、レジスト組成物及びそれを用いるレジストパターン形成方法
JP6919838B2 (ja) 2015-08-31 2021-08-18 三菱瓦斯化学株式会社 リソグラフィー用下層膜形成材料、リソグラフィー用下層膜形成用組成物、リソグラフィー用下層膜及びその製造方法、パターン形成方法、樹脂、並びに精製方法
CN107924131B (zh) 2015-08-31 2020-12-25 三菱瓦斯化学株式会社 光刻用下层膜形成材料及其组合物用于形成光刻用下层膜的用途、以及抗蚀图案形成方法
CN108137478B (zh) 2015-09-10 2021-09-28 三菱瓦斯化学株式会社 化合物、其组合物、纯化方法以及抗蚀图案形成方法、非晶膜的制造方法
US10042251B2 (en) 2016-09-30 2018-08-07 Rohm And Haas Electronic Materials Llc Zwitterionic photo-destroyable quenchers
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
KR102435507B1 (ko) * 2019-07-31 2022-08-24 일동제약(주) 신규 벤조퓨란 유도체 및 이의 용도
CN113929645B (zh) * 2021-12-15 2022-03-11 长沙普济生物科技股份有限公司 一种光催化合成苯并呋喃基氨基酸表面活性剂的方法
CN117045635A (zh) * 2022-05-13 2023-11-14 中国海洋大学 一种3-苯基二苯并呋喃类化合物在药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9711988A (pt) * 1996-09-04 1999-08-24 Warner Lambert Co Inibidores de metaloproteinase de matriz e seus empregos terap-uticos
WO1998009957A1 (en) * 1996-09-04 1998-03-12 Warner-Lambert Company Compounds for and a method of inhibiting matrix metalloproteinases
US6677355B1 (en) * 1999-08-18 2004-01-13 Warner-Lambert Company Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
MXPA01013172A (es) * 2001-02-14 2002-08-21 Warner Lambert Co Inhibidores sulfonamida de metaloproteinasa de matriz.
US20030157110A1 (en) * 2002-01-07 2003-08-21 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
EP2074107A2 (en) * 2006-10-27 2009-07-01 Wyeth a Corporation of the State of Delaware Tricyclic compounds as matrix metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2010526106A5 (cg-RX-API-DMAC7.html)
RU2013120064A (ru) Композиции и способы лечения глазного отека, неоваскуляризации и связанных с ними заболеваний
JP2007516173A5 (cg-RX-API-DMAC7.html)
JP2017538750A5 (cg-RX-API-DMAC7.html)
RU2491285C2 (ru) Органические соединения
RU2352568C2 (ru) [1,2,4]оксадиазолы (варианты), способ их получения, фармацевтическая композиция и способ ингибирования активации метаботропных глютаматных рецепторов-5
JP2006513258A5 (cg-RX-API-DMAC7.html)
JP2009525984A5 (cg-RX-API-DMAC7.html)
JP2010533158A5 (cg-RX-API-DMAC7.html)
RU2009109147A (ru) Органические соединения
CA2656915A1 (en) Human protein tyrosine phosphatase inhibitors and methods of use
RU2011133833A (ru) Способы лечения синдрома сосудистой утечки
JP2005526815A5 (cg-RX-API-DMAC7.html)
JP2010540462A5 (cg-RX-API-DMAC7.html)
JP2006502134A5 (cg-RX-API-DMAC7.html)
JP2008526866A5 (cg-RX-API-DMAC7.html)
JP2015509510A5 (cg-RX-API-DMAC7.html)
RU2017125520A (ru) Соединения, ингибирующие parg
RU2004127928A (ru) Производные морфолинилмочевины для использования в лечении воспалительных заболеваний
JP2010506825A5 (cg-RX-API-DMAC7.html)
JP2013514308A5 (cg-RX-API-DMAC7.html)
JP2007523905A5 (cg-RX-API-DMAC7.html)
JP2006503009A5 (cg-RX-API-DMAC7.html)
JP2009524677A5 (cg-RX-API-DMAC7.html)
JP2008503497A5 (cg-RX-API-DMAC7.html)